Arvinas, Inc. financial data

Symbol
ARVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
395 Winchester Ave, 5 Science Park, New Haven, CT
State of incorporation
DE
Fiscal year end
December 31
Former names
ARVINAS HOLDING COMPANY, LLC (to 9/28/2018)
Latest financial report
10-K - Q4 2024 - Feb 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 426 % +9.88%
Debt-to-equity 102 % -16.1%
Return On Equity -33.8 % +52%
Return On Assets -16.8 % +47.3%
Operating Margin -95 % +81.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68.8M shares
Common Stock, Shares, Outstanding 68.8M shares +1.18%
Entity Public Float 1.8B USD +38.9%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 71.9M shares +29.6%
Weighted Average Number of Shares Outstanding, Diluted 71.9M shares +29.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 263M USD +236%
Research and Development Expense 348M USD -8.3%
General and Administrative Expense 165M USD +64.9%
Operating Income (Loss) -250M USD +37.7%
Nonoperating Income (Expense) 51.9M USD +38%
Income Tax Expense (Benefit) 600K USD -33.3%
Net Income (Loss) Attributable to Parent -199M USD +45.8%
Earnings Per Share, Basic -2.77 USD/shares +58.2%
Earnings Per Share, Diluted -2.77 USD/shares +58.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 101M USD -67.8%
Marketable Securities, Current 939M USD -1.1%
Accounts Receivable, after Allowance for Credit Loss, Current 5.7M USD
Assets, Current 1.07B USD -16.6%
Property, Plant and Equipment, Net 7M USD -39.1%
Operating Lease, Right-of-Use Asset 9M USD +260%
Assets 1.09B USD -16.3%
Accounts Payable, Current 13.4M USD -24.7%
Employee-related Liabilities, Current 22.4M USD -12.8%
Contract with Customer, Liability, Current 156M USD -4.17%
Liabilities, Current 230M USD -10.6%
Contract with Customer, Liability, Noncurrent 292M USD -24.4%
Operating Lease, Liability, Noncurrent 7.3M USD +1360%
Liabilities 530M USD -17.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1M USD
Retained Earnings (Accumulated Deficit) -1.53B USD -14.9%
Stockholders' Equity Attributable to Parent 562M USD -14.9%
Liabilities and Equity 1.09B USD -16.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -97.5M USD -6.91%
Net Cash Provided by (Used in) Financing Activities 1.6M USD +6.67%
Net Cash Provided by (Used in) Investing Activities -128M USD -192%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 68.8M shares +1.18%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -224M USD -557%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 101M USD -68.3%
Deferred Tax Assets, Valuation Allowance 471M USD +15.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 473M USD +15%
Operating Lease, Liability 9.1M USD +279%
Payments to Acquire Property, Plant, and Equipment 100K USD -90.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -195M USD +44.5%
Lessee, Operating Lease, Liability, to be Paid 10.7M USD +328%
Property, Plant and Equipment, Gross 32.6M USD 0%
Operating Lease, Liability, Current 1.8M USD -5.26%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.9M USD +280%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.4M USD +20%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.6M USD +1500%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2M USD
Deferred Tax Assets, Operating Loss Carryforwards 31.7M USD -51.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 5.9M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.1M USD
Operating Lease, Payments 500K USD 0%
Additional Paid in Capital 2.09B USD +4.84%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 88.2M USD +23.2%
Interest Expense 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%